Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


PINL:CTABF - Post by User

Comment by canaken1on Sep 27, 2018 3:39pm
166 Views
Post# 28703658

RE:RE:RE:RE:RE:RE:RE:RE:Company is poised to grow!

RE:RE:RE:RE:RE:RE:RE:RE:Company is poised to grow!Julian:-  How are you  doing. I bought 15k shares @ $0.65 and sold all but 500 shares @  $1.9, might get back in @ $1.2.   I personally doubt this facility will be built here as Canntab is very legally connected with EMC. However, just for argument sake. 

If Canntab would be lucky enough to get 10K sq.ft at $300K per year, FSD  management's intelect would be questionable. This represents $2.5 /sq.ft/month. For entire US, industrial space rental average price for 2018 is US $5+/sq.ft.  and Canadian average rates are usually higher.  Now lets just take your figure of  $300K over a 25year lease. This represents $7.5million which will have to be paid as per a yet to be determined agreement. Next, 

This entire envelop builiding of 10K sq.ft. space will now have to be converted into  a ISO9000 series facility with a minimum of Class 100,000 micron air filtration for GMP certification. ie a stand alone environment to prevent any cross contamination from the rest of the building . $$$$$$$ millions. Once this is achieved, manufacturing equipment, staff selection and security clearance of staff follows. 2 to 3 months minimum.  ie $$$$$$$$  Next

Application to health Canada for License approval. Time.not  < 4 months...?????.ie  $$$$ used to be about $3 million /application cost. Now ???

I suggest you read Cannabis Application Guide lines and requirements from HealthCanada. Also 

See Smart_ Money post below  and scroll down to Forward Looking Statements  where it states "In Particular  , this release contains forward-looking information relating to the development of the Corporation's indoor cannabis facility and its business goals and objectives......




<< Previous
Bullboard Posts
Next >>